ugichem's Grant

ugichem raised a round of funding on August 06, 2011. Investors include FFG.

ugichem is developing antisense drugs based on its proprietary Ugimer platform for unmet medical needs in immune-mediated inflammatory diseases (IMID). Ugimers overcome the shortcomings of standard a…

Articles about ugichem's Grant: